Systematic Financial Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.2M Sell
1,484,539
-35,781
-2% -$121K 0.1% 168
2025
Q4
$4.94M Sell
1,520,320
-2,471
-0.2% -$8.32K 0.12% 159
2025
Q3
$4.37M Sell
1,522,791
-148,926
-9% -$380K 0.11% 156
2025
Q2
$4.03M Buy
1,671,717
+135,534
+9% +$285K 0.11% 159
2025
Q1
$3.39M Sell
1,536,183
-113,361
-7% -$448K 0.1% 163
2024
Q4
$8.99M Buy
1,649,544
+37,383
+2% +$241K 0.23% 132
2024
Q3
$13.4M Buy
1,612,161
+206,499
+15% +$1.79M 0.34% 119
2024
Q2
$10.1M Sell
1,405,662
-99,491
-7% -$859K 0.31% 124
2024
Q1
$13M Buy
1,505,153
+180,832
+14% +$1.22M 0.36% 114
2023
Q4
$8.67M Buy
1,324,321
+150,234
+13% +$971K 0.26% 133
2023
Q3
$11.7M Buy
1,174,087
+64,472
+6% +$708K 0.38% 110
2023
Q2
$13.8M Buy
1,109,615
+322,878
+41% +$4.36M 0.44% 105
2023
Q1
$11M Buy
786,737
+62,991
+9% +$905K 0.36% 116
2022
Q4
$10.4M Buy
+723,746
New +$11.4M 0.34% 120

Other funds holding MRVI